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Background: The autograft is still considered the gold standard for the treatment of
bone defects. However, given the significant morbidity of the donor site with which it
has been associated, alternative substitutes for bone grafts have been developed. In the
present study, a bone substitute composed of CaP biphasic bioceramics obtained from
shark teeth was used (BIOFAST-VET).
Objective: The objective of this study is to evaluate the efficacy of a marine bioapatite
in the veterinary clinical field using it as a bone-grafting scaffold in dogs and cats.
Methods: The biomaterial was randomly distributed in 6 veterinary clinical centers
in Spain and was used in 24 cases (20 dogs and 4 cats) including 14 fractures, 9
arthrodesis, and 1 bone cyst. Grains between 500 and 2,000µm were used. Inclusion
and exclusion criteria were established. The time of consolidation and functional recovery
were quantitatively and qualitatively assessed. For this, a follow-up was carried out at 2,
4, 8, and 12 weeks, included radiographic images, physical examination and sharing the
feedback with the owners.
Results: Nineteen cases completed the study (18 dogs and 1 cat; 11 fractures, 7
arthrodesis, and 1 bone cyst). The remaining five were excluded because they did not
complete the radiographic follow-up (three cats and two dogs), being three arthrodesis
and two fractures. In 18 of 19 cases, the use of the biomaterial was successful; the
remaining one failed due to causes not related to the biomaterial. There were no systemic
or local adverse reactions. Eighteen patients had a good functional recovery. The average
consolidation time was 5.94 weeks in dogs with fractures and arthrodesis, not finding
statistically significant differences between sex, weight, and procedure.
Conclusions: This biomaterial is presented as a very suitable candidate for orthopedic
surgery in the veterinary field. Preliminary results showed that its use reduces
consolidation time in dogs with fractures and arthrodesis. In addition, no adverse
systemic or local reactions have been observed derived from its use.
Keywords: hydroxyapatite, β-tricalcium phosphate, biomaterials, bone regeneration, bone substitutes, veterinary
orthopedics, marine bioapatites
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INTRODUCTION
Bone grafts are currently very required in orthopedic medicine
and dental and maxillofacial surgery for regenerating, repairing,
or replacing dental pieces or bone defects. Among the main
applications of bone fillings are the reconstruction of missing
bone cavities, congenital malformations, or bone atrophies.
Moreover, they are used to promote bone regeneration in
traumatic tissue damage or injuries (1). In maxillofacial
and dental surgery, bone graft scaffolds are commonly used
to contribute to the suitable environment for periodontal
regeneration and maxillary sinus elevation, to repair defects after
teeth extraction and/or in cases of implant placement (2–4).
In the veterinary orthopedics field, the gold standard is still the
utilization of fresh cancellous bone grafts for enhancing defect
healing. However, over the past two decades, the application of
artificial bone grafts has been augmenting (5).
Allogeneic (cadaveric) grafts and deproteinized (xenogenic)
bovine bone grafts are also used because of their greater
osteoconduction, along with the mechanical performance of
repairing tissues (1).
In the case of allografts, they have been mostly used as
substitutes for autogenous bone grafts, but low bone fusion rate
and risk of disease transmission have been observed as significant
problems (6). Deproteinized bovine bone has shown excellent
properties because of its excellent osteoconductive capacity and
biocompatibility (7), as well as a long-term remain within the
matrix of the host bone (8).
These evidences justify continued sacrifices to develop
effective synthetic substitutes for bone grafting. The discovery of
calcium phosphate ceramics and other related biomaterials has
provided a better control of the resorption process improving the
capacity of the materials in the bone regeneration (4).
Hydroxyapatite (HA) is the principal inorganic constituent of
vertebrate bone, and it is also lodged in the dentin and tooth
enamel (9). The characteristics of HA have been investigated
for several decades. Posner et al. (10) proposed its crystalline
structure from the analysis of a monocrystal (11). Its ionic
character makes it a stiff, refractory (12), and insoluble ceramic
(13), with a melting point higher than 1,500◦C (12).
This calcium phosphate, which can be acquire synthetically,
has properties of biocompatibility, non-toxicity, chemical
stability, osteoconduction, and bioactivity. Such properties make
the material very practical for medical uses. HA can be used as a
replacement for small parts of bone, reinforcement in composite
materials, cavity filling in dentistry, and coating of metal surfaces
for implants (14, 15).
Synthetic sources, as opposed to natural ones, in addition
to the good results regarding osseointegration, provide high
availability, innate reproducibility, and versatility to be integrated
in concrete formulations for specific applications. Thereby, Landi
et al. (16) revealed theHAhas a high potential as a bone substitute
replaced with strontium and magnesium in the cellular reply
Abbreviations: µm, micrometer; ◦C, degrees Celsius; BMP, bone morphogenetic
proteins; BV, BIOFAST-VET; h, hour; HA, hydroxyapatite; Hz, Hertz; kg, kilogram;
mm, millimeter; min, minute; P, significance level; TCP, tricalcium phosphate.
(16). Composite materials were proposed as another strategy
to increase osteoconductivity and biocompatibility, providing
an adequate resorption, like Shih et al. (17), who have tested
bone generation in animal models with HA and resorbable
dehydrated calcium sulfate (17). Chazono et al. (6) got a high
apposition rate of minerals in rabbit bone defects of highly pure
b-tricalcium phosphate (β-TCP) powder mixed with hyaluronic
acid, compared to pure β-TCP in blocks (6). Bioactive glasses
are very active materials that induce positive regulation of
genes related to differentiation and osteoblast proliferation. As
a result, they have excellent biological behavior, thanks to their
osteoconductive characteristics (18, 19).
Some case reports provided details about the use of different
bone substitutes in the veterinary field. One of this is a successful
correction of a bone deformity where the distal tibia is turned
inward toward the body (pes varus) in two Teckels. For this,
a synthetic β-TCP wedge was used to fill in defects made with
osteotomies. Eight weeks after the intervention, the bone was
integrated. The TCP blocks were entirely resorbed after 4months,
and remodeling at the osteotomy site was observed (20, 21).
In another investigation, another method was used mixing β-
TCP granules with the patient’s own blood and was used as a
bone substitute in defects located in long bones of 13 patients
(22). The treatment of an atrophic non-union in the distal
radius area of a Yorkshire Terrier was also investigated, using a
three-dimensionally printed β-TCP scaffold with morphogenetic
proteins (22).
Nowadays, numerous investigations are being carried out to
obtain biomaterials of marine origin. The fibrillar collagen of
the sea urchin has been shown to be a very valuable biomaterial
for the production of skin-like scaffolds (23). Recent researches
have demonstrated the possibility of obtaining bone substitutes
of marine origin, BIOFAST-VET (BV). This novel product was
designed to repair and regenerate bone tissue. It is made from
a ceramic material obtained from the reassessment of a fish by-
product, shark teeth (Prionace glauca). It is a very abundant and
low-cost raw material at present (1, 24).
The composition, morphology, and characterization (Raman
and XRD techniques) of shark teeth–derived bioapatites have
been studied (1, 24–28) and revealed a globular porous structure
with biphasic composing ∼70% apatitic (HA, apatite-CaP,
fluorapatite) and∼30% non-apatitic phase (whitlockite, β-TCP),
and contributions of F, Na, and Mg. This composition and
structure promoted a significantly higher bone mineral density
in a rodent model after 3 weeks of healing compared with a
commercial artificial biphasic HA/β-TCP (60%/40%) bone graft
(P < 0.05). In addition, 1-mm marine bioceramics developed
higher osteointegration and horizontal growth of bone tissue at
the central area of the defect (1, 28).
A new advantage is that this biomaterial is environmentally
friendly, because it is a natural product, gives value to fish waste,
and reduces the risk of disease transmission, as it comes from a
species phylogenetically far from our domestic species. Viewing
the promising results (histological and radiographic) obtained
in an in vivo study carried out on rodents (1), the mean goal
of this research is to evaluate the capacity of this compound as
a bone substitute in the veterinary clinical field, being used in
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several orthopedic procedures in dogs and cats, trying to avoid
the complications derived from the non-union.
METHODS
Biomaterial Obtaining Method
The fabrication method of the bone substitute of marine origin
BV is based on pyrolytic techniques in order to remove the
organic compounds. The natural precursor (shark teeth P.
glauca) is heated to 950◦C for 12 h using a heating ramp of 2◦C
min−1 and a cooling ramp of 20◦Cmin−1, as described elsewhere
(1, 24). Once pyrolyzed, the powders were subjected to a sieving
process to select macrogranules in the diameter ranges of 0.5
to 1.0mm, 1.0 to 2.0mm, and 2.0 to 3.0mm. The sterilization
method used was gamma radiation (Aragogamma S.L.) (1, 24).
Study Design
The study was designed by a multidisciplinary group made up
of researchers from the School of Industrial Engineering of Vigo
(PM and JA) and the Faculty of Veterinary Medicine of Lugo
(A, FM, and M), with the collaboration of specialists in human
orthopedic surgery (R). The material had previously passed
biocompatibility tests and a complete histological evaluation
in preclinical studies (1, 24, 28). The initial approach was to
elucidate in which clinical situations the material object of
study would be useful. Once a consensus was reached, the
data collection method was designed. Afterward, a veterinary
centers, clinics, and hospitals list in Spain was compiled, with
sufficient orthopedic casuistry that could be included in the
study. Randomly, six were selected (CV Miralbueno, Hospital
Veterinario Vetpets, Hospital Veterinario Lepanto, CV Fauna,
CV Sauces, CV El Parque). Because of the randomization, the
sample of veterinary centers chosen is heterogeneous in terms of
the age of the veterinary team, medical equipment, knowledge,
and geographical location.
All of them were provided with the available documentation
about the biomaterial, and the handling protocol was explained
to the staff. Material of different grain sizes (diameter range =
500–1,000 and 1,000–2,000µm) was supplied to facilitate its use
and adapt it to the size of the defect to be filled. They were also
provided with a list of techniques in which the use of BV would
be indicated.
At the end of each procedure, the veterinarians had to fill out
a form (Supplementary Material 1) about the clinical use of the
biomaterial (one per case). The results of this survey, along with
the x-rays, were analyzed and compared by a committee of two
outside blind experts who came to a consensus about whether the
evolution was satisfactory or not.
Clinical Cases and Criteria Selection
The legal owners of the animals signed an informed consent
about the use of BV as a part of the treatment.
Twenty-four clinical cases (20 dogs and 4 cats) have been
reported in which bone substitute of marine origin has been used
to improve bone healing and fill critical defects. Fourteen of the
cases were treatment of fractures, nine arthrodesis, and a benign
bone cyst.
The patients were selected strictly according to their clinical
status and a set of established criteria: patients of any age, sex, or
weight; without any disease or systemic infection; and skeletally
mature. The exclusion criteria were disease or systemic infection,
malignant tumors, severe renal dysfunctions, a greater anesthetic
risk, and animals with uncontrolled bone metabolism.
Radiographic Evaluation
Radiographic images were taken before surgery to evaluate the
injury and, shortly after, to evaluate the success of the procedure.
To assess the evolution of the patients’ progress, radiographic
assessments were performed at 2, 4, 8, and 12 weeks after the
surgery. Two radiographic views were made (anteroposterior and
lateral). The follow-up consultations included a general physical
examination, control radiographs, and feedback with the client
to monitor the process. Each radiograph was evaluated by a stage
score of 1 to 5 points to set the consolidation time (1: not visible
callus formation; 2: barely visible callus formation; 3: scattered,
not homogeneous callus; 4: uniform, mature callus formation;
5: very active, hyperthrophic callus formation) (29). The results
were evaluated by the veterinary specialist of the entity and later
by a panel of two blind outside experts.
Epidemiological Survey
An epidemiological survey (Supplementary Material 1), as
stated above, was sent to all the veterinarians for each case,
including the patients’ clinical history (anamnesis, diagnosis,
surgical treatment, and progress), functional recovery and
information related to the biomaterial and its handling (grain
size used, difficulty in using it, mixing with another material
or substance, advantages over other fillings), and a radiographic
report. Finally, the veterinarians provided a final report on their
experience in the clinical use. Later, the obtained information
was reviewed by a panel of blind independent experts to see the
suitability of the treatment and its correct evolution.
Functional Recovery
Functional recovery was evaluated by the clinicians of the centers
in each revision, using a simple scale (1–9, 11–16) with three
levels: good (12–16), regular (6–9, 11), and poor (1–5), indicating
total, partial, and no recovery of function, respectively. The
criteria that were evaluated were as follows: lameless, pain on
palpation, and weight-bearing (Table 1) (30, 31).
Statistical Analysis
A statistical analysis was carried out with the consolidation
time in search of statistically significant differences regarding
sex (males and females), weight (three groups: (a) <5 kg, (b) 5–
20 kg, (c) >20 kg), and procedure (internal or external fixation
and arthrodesis).
Statistical analysis was performed with the computer program
SigmaPlot R© 12.5 for Windows (Systat Software Inc., San José,
CA, United States). A value of p < 0.05 was considered
statistically significant. The descriptive study of the population
was shown as the mean ± SD. The normality of variances
was assessed using the Shapiro–Wilk test. To determine the
differences between the groups for non-categorical variables
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TABLE 1 | Functionality recovery scoring system for assessing patients (30, 31).
Criteria Score Clinical evaluation
Lameless 1 Not walk
2 Severe limp when walking
3 Moderate limp when walking
4 Slight limp when walking
5 No limp. Walk normally
Pain on
palpation
1 Patient cannot be palpated
2 Severe signs; patient vocalizes or becomes aggressive
3 Moderate signs; patient pulls limb away




1 Non–weight-bearing standing and walking
2 Partial weight-bearing standing; non–weight-bearing walking
3 Partial weight-bearing standing; non–weight-bearing walking
4 Normal standing; favors affected limb when walking
5 Equal on all limbs standing and walking
(weight), a one-way analysis of variance was done. Categorical
variables (sex and procedure) were assessed using t-test and
one-way analysis of variance.
RESULTS
Nineteen cases completed the study (18 dogs and 1 cat; 12 males
and 7 females; 11 fractures, 7 arthrodesis, and 1 bone cyst)
(Table 2). The remaining five were excluded because they did
not complete the radiographic follow-up (three cats and two
dogs; three arthrodesis and two fractures). The age of the canine
patients ranged from 1 to 15 years (average age of 7 years),
being 10 males and 8 females, with weight ranging from 2.5
to 36 kg (average of 16.4 kg). The feline patient was a 3-year-
old male and of 3.5-kg weight. In all cases except for one (case
11), the functional recovery was good, and no complications
were recorded.
The statistical analysis was carried out only in dogs, because
the sample in cats was finally not representative (one case),
and only with arthrodesis and fractures (with external and
internal fixation). Given the hypothesis whether sex or weight
influences the time of consolidation, no statistically significant
differences were found. Also, no statistically significant
differences were found when comparing the procedures
made (Table 3).
The bone substitute of marine origin (Figure 1) was
applied mixed with the patient’s own blood, previously
extracted. In all cases, BV was used to improve bone
healing, fill in critical defects, and complement the
recommended procedures.
The suitability of the bone substitute of marine origin was
studied in different types of orthopedic pathologies in veterinary
field. In specific, BV was used as a bone substitute and to perfect
traditional methods (bone defects caused by cysts, external and
internal fixation of breakages, and arthrodesis).
In all of the cases, there were no reports on adverse reactions at
the grafting site or at systemic level related to biomaterial. Except
for case 11, there were no records of postoperative infection
or foreign body reaction, regardless of the amount of grafted
material. In case 11, because it was an old fracture by firearm
and remitted from a less specialized clinic, the infection was
not treated properly from the beginning, and the filling was not
successful, producing a fistula after 2 weeks. The group that
reviewed the case considered that, in this case, the use of the
biomaterial had been contraindicated.
The efficacy of surgical treatments was performed by
clinical examination and radiographic evaluation at the times
established. In most of the successful cases, postsurgical x-
ray controls indicated high rates of bone regeneration, being
the mean consolidation time 5.94 weeks (ranging from 4 to 9
weeks). Except in case 11, all the bone defects healed without
complications 12 weeks after the procedure.
The retrospective study of the questionnaire revealed that all
the veterinarians who used BV agreed that it was an easy to
use biomaterial. They asserted that the consolidation time was
reduced, as well as the acceleration of joint fusions in cases
of arthrodesis.
Clinical Cases Description
Clinical Case 1. Dog, English setter breed, female of 30 kg,
presented by an old failure due to a panarthrodesis infection with
stepped plate in the carpal joint. It was decided to place a titanium
plate on the dorsal side, using two crossed needles and a BV graft.
The results were good, and the bone substitute helped the bone
to consolidate faster (Figure 2).
Clinical Case 2. Dog, German shepherd breed, adult male of
35 kg, presented an old fracture (3 months) of two metatarsals.
We performed tarsometatarsal arthrodesis from the calcaneus
to the metatarsals by a lateral approach and using a BV graft.
The radiographic evaluation and the clinical examination were
performed up to 8 weeks, a good and effective osseointegration
being observed.
Clinical Case 3. Dog, Yorkshire breed, adult, male of 2.5 kg,
presented a distal third fracture of the radius and ulna. An
external type II fixator with five metallic thread needles and a
BV graft is placed in the fracture site. It is a case in which the
external fixation is not ideal, since the literature (32–35) describes
the possibility of a non-union in fractures of the third distal of
the radius in small breeds, being able to cause deformations, and
requiring new procedures and even amputations. The use of the
bone graft of marine origin resulted in rapid ossification of the
fracture, within 4 weeks after the surgery, a complete ossification
being observed at the fracture site at 6 weeks.
Clinical Case 4. Mixed-breed dog, adult, 15-kg male,
presented a slightly comminuted transverse diaphyseal fracture
of the ulnar and radius of the left limb. It was stabilized with
an internal fixation plate and a BV graft at the fracture site. At 4
weeks, consolidation was observed, and at 6 weeks, the plate was
removed. At 8 weeks, the fracture site was completely remodeled
(Figure 3).
Clinical Case 5. Dog, Yorkshire breed, adult, male of 2.5 kg,
presented non-union in a distal third fracture of the radius and









































TABLE 2 | Summary of patients treated with BIOFAST-VET.
No Species/Breed
Age/Gender/Weight




1 Dog/English Setter/10/F/30 kg Old failure due to an arthrodesis infection
with steppped plate in carpal joint
Carpus
arthrodesis
1–2mm 7 Good, none
2 Dog/German Shepherd/Adult/M/35 kg 2 fractured metatarsals Tarsal arthrodesis 1–2mm 8 Good, none
3 Dog/Yorkshire/Adult/M/2.5 kg Distal third fracture of radius and ulna ESF 1–2mm 4 Good, none
4 Dog/Crossbreed/Adult/M/15 kg Slightly comminuted diaphyseal fracture of
radius and ulna
ISF 0.5–1mm 4 Good, none
5 Dog/Yorkshire/Adult/M/2.5 kg Distal third fracture of radius and ulna ISF 0.5–1mm 5 Good, none
6 Dog/Crossbreed 1/F/13 kg Highly comminuted femoral diaphyseal
fracture
ESF Tie in 1–2mm 6 Good, none
7 Dog/Crossbreed Adult/F/8 kg Transverse fracture of radius and ulna ISF 1–2mm 4 Good, none
8 Dog/Crossbreed Adult/F/11 kg Radius and ulna fracture ISF 0.5–1mm 8 Good, none
9 Dog/Crossbreed Adult–F−12 kg Intercondylar fracture ISF with 2
condylar needles
1–2mm 8 Good, none
10 Dog/Crossbreed Adult/M/12 kg Tibia and fibula fracture ISF 1–2mm 7 Good, none
11 Dog/Crossbreed Adult/M/16 kg Old femoral fracture by firearm ISF 1–2mm — Poor, infection and
biomaterial expulsion
12 Dog/German Shepherd/8/M/36 kg Highly comminuted open fracture of the
tibia
Tarsal arthrodesis 1–2mm 4 Good, none
13 Dog/Teckel 2–F/10 kg Benign bone cyst Bone biopsy and
defect filling
0.5–1mm 8 Good, none
14 Dog/Crossbreed/8/F/3 kg Open tibial and tarsal fracture Tarsal arthrodesis 1–2mm 8 Good, none
15 Dog/Boxer 1.5/M/29 kg Severe injuries to the tendons of the tarsal
joint
Tarsal arthrodesis 1–2mm 6 Good, none






1–2mm 6 Good, none
17 Cat/European Common/3/M/3.5 kg Tibial fracture ESF 1–2mm 4 Good, none
18 Dog/English Setter/3/M/27 kg Severe radiocarpal joint injuries Carpal arthrodesis 1–2mm 8 Good, none























































García-González et al. Marine Bioapatites in Veterinary Orthopedics
ulna, a relatively large isolated bone fragment being observed. An
internal fixation plate was placed, the necrosed bone fragment
is removed, and BV graft was added to keep the length of the
bone. The bone substitute provided a faster consolidation of
the fracture. Eight weeks later, radiographs revealed a complete
ossification of the fracture site.
Clinical Case 6. Mixed-breed dog, female of 8 kg and 1 year
old, presented a highly comminuted femoral diaphyseal fracture
in the left posterior limb. It was a complex fracture in a growing
dog, which occurred 5 days before the procedure. It was decided
to perform a functional reduction and stabilized the fracture with
an external tie-in fixator and a BV graft. Two weeks later, an early
ossification was radiographically observed, integrating the graft
grains perfectly into the new tissue.
Clinical Case 7. Mixed-breed dog, adult, female of 8 kg,
presented malunion of a transverse fracture of radius and ulna
in the left anterior limb. Non-functional bone tissue formation
TABLE 3 | Statistical parameters about the time of consolidation compared with
the sex, weight, and procedure (p < 0.05 was considered statistically significant).
Variable Mean and SD (weeks) p
Sex Males 6 ± 1.7
0.233
Females 7 ± 1.52
Weight Group (a): < 5 kg 5.67 ± 2.08
Group (b): 5–20 kg 6.63 ± 1.77 0.714
Group (c): >20 kg 6.50 ± 1.52
Procedure Fractures Internal fixation 6.14 ± 1.77
0.436
External fixation 5.00 ± 1.41
0.433
Arthrodesis 6.71 ± 1.50 —
was observed. The fragments were separated with a surgical saw
and aligned correctly. Finally, an internal fixation plate and BV
graft were placed to favor the ossification process. The patient
evolved favorably. At 7 weeks, a remarkable advance in the radial
ossification process was observed radiographically. The filling
was practically reabsorbed and integrated into the new tissue. The
ulna did not ossify because it was not correctly aligned (Figure 4).
Clinical Case 8. Mixed-breed dog, adult, female of 11 kg,
presented a radius and ulna fracture. After studying the situation,
it was decided to use an internal fixation with a locking plate and
a BV graft in the fracture center. Eight weeks later, radiographs
showed a complete ossification of the fracture site.
Clinical Case 9. Mixed-breed dog, adult, female of 12 kg,
presented an intercondylar humerus fracture of the left forelimb.
The fracture was stabilized by placing two needles and an internal
fixation plate with the BV graft. Radiographs revealed a correct
evolution and consolidation at 7 weeks.
Clinical Case 10. Mixed-breed dog, adult, male of 12 kg,
presented a fracture of the tibia and fibula. It proceeded to
stabilize the tibia fracture using an internal fixation plate with
six screws. In this case, no follow-up radiographs are available,
but the owners stated that the animal had been using the
paw for support and did not show any pain 2 weeks after
the procedure.
Clinical Case 11. Mixed-breed dog, adult, male of 16 kg,
presented an old humerus fracture by firearm. Fractures caused
by firearm represent a delicate situation in traumatology (36). In
general, they are contaminated, so they tend to become infected,
being complicated to treat. In this case, the fracture was old, and
the patient was referred from a poorly specialized clinic where an
attempt has been previously made to stabilize the fracture with
an external fixator. The fracture was stabilized with an internal
fixation plate and a BV graft aimed at promoting ossification.
FIGURE 1 | Biomaterial vial (A), biomaterial granules (B), preparation of the biomaterial mixture for intraoperative application with autologous blood (C).
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FIGURE 2 | Case 1. Dorsopalmar radiographic images of the carpal joint infection. Preoperative radiographic image (A); postoperative radiographic image (B);
Postoperative control 4 weeks after surgical procedure (C); postoperative control 12 weeks after surgical procedure (D).
FIGURE 3 | Case 4. Mediolateral and laterolateral radiographic images of radius and ulna fracture. Preoperative radiographic image (A); postoperative control 4
weeks. Consolidation is observed (B); postoperative control 8 weeks. Remodeling is observed (C).
Unfortunately, after 2 weeks, the infection continued, and
the bone substitute was expelled from the body with the
suppuration. In this case, the use of BV did not have any
result because the local infection had not been properly treated
well (Figure 5).
Clinical Case 12. Dog, German shepherd breed, male
of 36 kg, presented a highly comminuted open fracture of
the tibia, with great destruction of soft tissue. In the first
procedure, a wall locking plate was placed. A week after
that, the patient presented an angular deviation of the
limb and plantigradism, because the plate was bent because
of the empty holes, and, in addition, presented a lesion
of the Achilles tendon, with rupture of the deep flexor.
Subsequently, it was proposed to solve everything with surgery.
A custom hybrid plate was designed, with locking screws,
to solve the angulation and achieve a tarsal, since it was
Frontiers in Veterinary Science | www.frontiersin.org 7 October 2020 | Volume 7 | Article 574017
García-González et al. Marine Bioapatites in Veterinary Orthopedics
FIGURE 4 | Case 7. Mediolateral radiographic images of the radius and ulna fracture. Preoperative radiographic image (A); postoperative control 4 weeks (B);
postoperative control 8 weeks. Remarkable ossification is observed. The material has been fully integrated and reabsorbed. The ulna is not ossifying because it was
not aligned properly (C).
FIGURE 5 | Case 11. Mediolateral radiographic images of an old femoral fracture by firearm. Preoperative reintervention radiographic image (A); postoperative control
2 weeks. Suppuration and elimination of the biomaterial can be observed (B).
not possible to suture the tendon. The callus formed was
broken to facilitate the alignment, and the BV graft was
incorporated. The result was very good, an almost perfect
alignment was achieved, and an almost perfect functionality
was granted. Radiographs showed a complete ossification at 8
weeks (Figure 6).
Clinical Case 13. Dog, Teckel breed, female of 10 kg,
presented an expansive lesion in the distal metaphysis of the right
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FIGURE 6 | Case 12. Highly comminute open fracture of the tibia correct by tarsal arthrodesis. Intervention (A); postoperative image (B); postoperative control 4
weeks (C); postoperative control 8 weeks, perfect ossification is observed (D).
humerus, with non-specific right axillary lymphadenopathy.
Bone biopsy was performed, and a benign unicameral bone cyst
was diagnosed. The defect was filled with a BV graft. Eight weeks
later, radiographs showed good consolidation (Figure 7).
Clinical Case 14. Mixed-breed dog, female of 3 kg, was hit
by a car and could not stand its posterior limbs. Radiographs
revealed a distal fracture of the right tibia, with several fragments
that reach the tarsal joint, destabilizing the joint. In the left
posterior limb, the patient presented hip dislocation. It was
decided to perform arthrodesis of the joint with an internal
fixation plate and a bone graft. Four weeks later, radiographs
revealed good remodeling, which was complete 8 weeks after the
procedure (Figure 8).
Clinical Cases 15 and 16. Dog, Boxer breed, female of 29 kg,
presented lesions in the left posterior limb, in the joint of the
tarsus in the right posterior limb, and in the carpal joint in the
right anterior limb.
- The left posterior limb had to be amputated because of
irreversible injuries. An endoprosthesis and exoprosthesis was
placed instead.
- In the right posterior limb, a partial arthrodesis of the joint was
performed because of damage to the tendons. A BV graft was
also placed.
- In the right anterior limb, there was no soft tissue coverage in
the distal two-thirds of the radius. There was neither carpus
nor metacarpals. An external fixator was placed; bandages
and treatment were applied until the entire limb was covered
with granulation tissue. At that point, a panarthrodesis was
performed, using a circular fixator and a BV graft.
The use of BV provided very good results to accelerate the joint
fusion because, in this case, there were three injured joints, and it
was essential to achieve a quick consolidation to recover mobility
as soon as possible. In addition, because of the serious soft tissue
injuries, the implant of the right posterior limb was exposed, so it
was vital to accelerate the consolidation to be able to remove the
implant and thus allow the tissue recovery. In this sense, the use
of BV was successful, allowing bearing weight normally on the
affected limbs.
Clinical Case 17. Cat, European Common breed,
male of 3.5 kg, presented a fracture of the tibia. We
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FIGURE 7 | Case 13. Preoperative radiographic image of humerus benign bone cyst (A); infiltration of the biomaterial (B); postoperative control 4 weeks image (C);
postoperative control 8 weeks image (D).
FIGURE 8 | Case 14. Preoperative caudocranial radiographic image of an open tibial and tarsal fracture (A); biomaterial graft intervention (B); postoperative control 4
weeks. Good remodeling can be observed (C); postoperative control 8 weeks. Completed remodeling can be observed (D).
performed a reduction thereof, with an external fixator
and a BV graft. At 8 weeks, a correct remodeling was
observed radiographically, but the external fixator was
not removed until after 12 weeks (Figure 9). In this case,
fracture has healed with axial distortion with help of
a BV.
Clinical Case 18. Dog, English setter breed, male of 27 kg,
presented severe carpal joint lesions. During the first procedure,
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FIGURE 9 | Case 17. Open tibial and ulna fracture in a cat (A); preoperative radiographic image (B); postoperative radiographic image (C); postoperative control 4
weeks (D); postoperative control 12 weeks (E).
it was decided to place an internal fixation plate carrying out
a carpal joint arthrodes, but 1 week after the procedure, the
implants had to be removed because of infection. Three weeks
later, the second procedure was performed, in which another
plate was placed on the dorsal side, employing a BV graft,
favoring a quick ossification. This allowed the removal of the
implants earlier than usual (after 2½ months) and the beginning
of rehabilitation.
Clinical Case 19. Mixed-breed dog, male of 17 kg, presented
with a multifragmentary fracture in the left femur. It was a very
unstable fracture that applied load on the osteosynthesis implant
in an extreme way, reducing its useful life. Therefore, a BV graft
was added to promote rapid ossification and to reduce the load
on the implant. BV met the expectations, and at 4 weeks, the
patient showed a good evolution and perfect support, despite a
very serious initial prognosis (Figure 10).
DISCUSSION
The present work demonstrated that porous globular bioapatites
are viable for use in veterinary orthopedics. In all cases, there
were no reports on adverse reactions at the grafting site or at
systemic level. Except for case 11, there were no records of
postoperative infection or foreign body reaction, regardless of
the amount of grafted material. In case 11, because it was an
old fracture by firearm and remitted from a less specialized
clinic, the infection was not treated properly from the beginning,
and the filling was not successful, producing a fistula after
2 weeks. Fractures caused by firearm represent a delicate
situation in traumatology (36). The group that reviewed the case
considered that, in this case, the use of the biomaterial had
been contraindicated.
Fractures are themost common large-organ traumatic injuries
(37). The normal and physiological reaction when a fracture
occurs includes a series of events: initial inflammatory reaction,
establishment of soft and subsequently hard callus and, finally,
bone remodeling (38, 39). In cases where this physiological
process does not occur, the surgery is indicated (40). Insufficient
blood nutrition, a disease that systematically affects, or an
infection of the bone callus can have a negative effect on the
regeneration of the bone, which can trigger a non-union (41).
In those situations where healing is not achieved, the use of
bone substitutes is indicated (42). The autologous graft remains
the gold standard in these types of situations, because it does
not trigger immunological reactions, provides growth factors
to help osteoinduction and is also part of the structure of the
new bone (40, 43, 44). Nevertheless, the use of autologous
bone has disadvantages: longer anesthesia, the availability of
autologous bone is limited, high morbidity of the donor site (risk
of intraoperative bleeding, pain, possibility of stress fractures),
increased chances of local infection, and risk of failure (5, 45–
47). It should also be noted that the amount of autologous bone
collected and the viability of the cells collected are limited, which
limits the application in situations where defects are critical (44).
These disadvantages can be avoided by using synthetic bone
substitutes instead of autologous bone. One of the advantages
of these bone substitutes is their ease of storage (43, 48, 49).
In this report, we presented a series of cases in which the BV
bone mineral substitute was shown to be an effective alternative
and without adverse effects. This biomaterial is an excellent
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FIGURE 10 | Case 19 Preoperative radiographic image of a multifragmentary femoral fracture (A); postoperative control 4 weeks (B); postoperative control
12 weeks (C).
ceramic scaffold to promote and strengthen the process of bone
regeneration. BV contains a large amount of HA, which is one of
the main components of the bone mineral matrix (50).
One of the challenges of using synthetic bone substitutes
is maintenance within the defect. The mixing of BV with the
patient’s own blood achieved the desired effect, and the escape
of the biomaterial was kept in the correct place. In addition,
cell congregations within blood clots are bioactive potentials that
favor the cure of the defect, promoting improved remodeling
(51). The mixing of the biomaterial with platelet-rich plasma
could also have been interesting, given the good results obtained
in a study in which it was used for the treatment of fractures in
dogs (29).
Other calcium phosphate ceramics have previously been
used as bone substitutes in the veterinary field, obtaining
good results in terms of improving the quality of life of the
patient, speed of bone healing, and decrease in morbidity. In
the mentioned research study (4, 48), the effectiveness of the
material in appendicular and maxillary/mandibular bone defects
was studied. The patients did not present any adverse effects at
the local or systemic level, and the functional recovery was good
in all cases, as in the present study. Despite being a preliminary
study, in the present study, shorter consolidation times were
obtained (5.94 vs. 9.07 weeks). However, controlled studies would
be needed to give more weight to this premise.
Despite not having found statistically significant differences
in the comparison of the consolidation time with sex, weight,
and procedure, a slight trend can be observed in a shorter
consolidation time in dogs of <5 kg and in males.
The present study has some limitations. The diagnostic
use of computed tomography would have been interesting to
assess the density of postsurgical bone mineralization and at
12 weeks in the defect. The use of questionnaires in owners
could have provided more quantitative data regarding the
recovery of the animal. No controlled group was available. The
statistical analysis of the age variable could have provided more
quantitative data, but it could not be done because all ages were
not available.
Seeing the promising results have been obtained in
this preliminary study, it would be very useful to carry
out controlled clinical trial to complement and provide
more quantitative and comparative data about the study of
this biomaterial.
CONCLUSIONS
In the present study, the viability of using globular porous
bioapatites of marine origin in the veterinary field has been
demonstrated. This biomaterial is presented as a very suitable
candidate for orthopedic surgery in the veterinary field. It
has been used successfully in 18 cases in which no local
or systemic adverse reactions related to the biomaterial
have been detected. Regarding the consolidation time,
it is observed that the use of this biomaterial in dogs
with arthrodesis and fractures can reduce it compared to
other biomaterials.
However, controlled clinical studies are needed to evaluate the
behavior of the biomaterial in different clinical settings.
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